Company profile
Absci Corp
NASDAQ:ABSIBiotechnology: Commercial Physical & Biological Resarch
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07317544 | phase1_2 | recruiting | 2025-12-03 | 2028-07-01 | Absci Pty Ltd. | Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia |
FDA applications (0)
No records yet.